top of page

CHO-K1/Rat β3-adrenoceptor Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0030C

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


The β3-adrenoceptor is a G-protein-coupled receptor primarily found on the surface of fat cells (adipocytes) and the smooth muscle of the urinary bladder. Its main roles are to stimulate the breakdown of stored fat (lipolysis) to increase energy expenditure and to promote relaxation of the bladder muscle, thereby increasing its capacity. Because of these key functions, the β3-adrenoceptor has become a significant therapeutic target, with agonists like mirabegron being successfully used to treat overactive bladder syndrome and others under investigation for their potential to combat metabolic disorders like obesity and type 2 diabetes.

 

Screeningbio’s CHO-K1/Rat β3-adrenoceptor cell line overexpress rat ADRB3 and is designed to detect increases in intracellular cAMP levels in response to agonist stimulation of the receptor. Cisbio HTRF cAMP kit can be used to detect the signal. 

Product Specifications

Target Type

GPCR

Species

Rat

HGNC Symbol

β3-adrenoceptor

Accession Number

NM_013108

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data

CHO-K1/Rat β3-adrenoceptor Agonist Assay. CHO-K1/Rat β3-adrenoceptor cells were treated with the reference agonist L-Adrenaline. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
CHO-K1/Rat β3-adrenoceptor Agonist Assay. CHO-K1/Rat β3-adrenoceptor cells were treated with the reference agonist L-Adrenaline. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.



Target Background


The β3-adrenoceptor is a G-protein-coupled receptor primarily found on the surface of fat cells (adipocytes) and the smooth muscle of the urinary bladder. Its main roles are to stimulate the breakdown of stored fat (lipolysis) to increase energy expenditure and to promote relaxation of the bladder muscle, thereby increasing its capacity.


Because of these key functions, the β3-adrenoceptor has become a significant therapeutic target, with agonists like mirabegron being successfully used to treat overactive bladder syndrome and others under investigation for their potential to combat metabolic disorders like obesity and type 2 diabetes.


Product Documentation



bottom of page